Steven Petrou
Fondateur chez PRAXIS PRECISION MEDICINES, INC.
Profil
Steven Petrou is the founder of Praxis Precision Medicines, Inc., where he currently holds the title of Chief Scientific Officer since 2018.
He founded the company in 2015.
Dr. Petrou is also the founder of RogCon, Inc. Dr. Petrou's former job was at The Florey Institute of Neuroscience & Mental Health, where he held the position of Director & Head-Department from 2018 to 2022.
Dr. Petrou's education includes undergraduate and doctorate degrees from the University of Melbourne.
Postes actifs de Steven Petrou
| Sociétés | Poste | Début |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Fondateur | 22/09/2015 |
RogCon, Inc.
 RogCon, Inc. Pharmaceuticals: MajorHealth Technology RogCon, Inc. engages in the discovery and development of novel treatments for SCN2A mutations that cause epilepsy, autism and other neurological disorders. The company was founded by Kelley Dalby, Steven Petrou and Alex Nemiroff and is headquartered in Miami Beach, FL. | Fondateur | - |
Anciens postes connus de Steven Petrou
| Sociétés | Poste | Fin |
|---|---|---|
The Florey Institute of Neuroscience & Mental Health
 The Florey Institute of Neuroscience & Mental Health Miscellaneous Commercial ServicesCommercial Services The Florey Institute of Neuroscience & Mental Health operates as brain research center. Its teams work on a range of serious diseases including stroke, epilepsy, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, Huntington’s disease, motor neuron disease, traumatic brain and spinal cord injury, depression, schizophrenia, mental illness and addiction. The company was founded in July 2007 and is headquartered in Parkville, Australia. | Directeur/Membre du Conseil | 01/11/2022 |
Formation de Steven Petrou
| University of Melbourne | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
RogCon, Inc.
RogCon, Inc. Pharmaceuticals: MajorHealth Technology RogCon, Inc. engages in the discovery and development of novel treatments for SCN2A mutations that cause epilepsy, autism and other neurological disorders. The company was founded by Kelley Dalby, Steven Petrou and Alex Nemiroff and is headquartered in Miami Beach, FL. | Health Technology |
The Florey Institute of Neuroscience & Mental Health
The Florey Institute of Neuroscience & Mental Health Miscellaneous Commercial ServicesCommercial Services The Florey Institute of Neuroscience & Mental Health operates as brain research center. Its teams work on a range of serious diseases including stroke, epilepsy, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, Huntington’s disease, motor neuron disease, traumatic brain and spinal cord injury, depression, schizophrenia, mental illness and addiction. The company was founded in July 2007 and is headquartered in Parkville, Australia. | Commercial Services |
